Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice

• 主要な著者: Dongmei Wang (著者), Jieying Liu (著者), Ling Zhong (著者), Lu Ding (著者), Qian Zhang (著者), Miao Yu (著者), Ming Li (著者), Xinhua Xiao (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Metformin and pioglitazone monotherapy have been proven to alter gut microbiota in diabetes and obesity. The present study aimed to investigated whether the combined administration of pioglitazone and metformin achieved superior protective effects on high-fat diet (HFD)-fed obese mice and elucidated...